Next Article in Journal
Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation
Previous Article in Journal
Osteoblastoma of the Jaws: Report of a Case and Review of Literature
 
 
Clinics and Practice is published by MDPI from Volume 11 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Palmar Dislocation of Scaphoid and Lunate

by
Khalid Koulali Idrissi
* and
Farid Galiua
Department of Orthopedic Surgery, Avicenne Hospital, Marrakesh, Morocco
*
Author to whom correspondence should be addressed.
Clin. Pract. 2011, 1(4), e87; https://doi.org/10.4081/cp.2011.e87
Submission received: 20 September 2011 / Revised: 20 September 2011 / Accepted: 12 October 2011 / Published: 23 November 2011

Abstract

A palmar dislocation of scaphoid and lunate is uncommon. We have found only 19 reported cases in the literature. We reported a simultaneous, divergent dislocation. The closed reduction followed by percutaneous pinning has given a good result without avascular necrosis of any carpal bone.
Keywords: palmar dislocation; scaphoid; lunate; orthopedic surgery palmar dislocation; scaphoid; lunate; orthopedic surgery

Share and Cite

MDPI and ACS Style

Koulali Idrissi, K.; Galiua, F. Palmar Dislocation of Scaphoid and Lunate. Clin. Pract. 2011, 1, e87. https://doi.org/10.4081/cp.2011.e87

AMA Style

Koulali Idrissi K, Galiua F. Palmar Dislocation of Scaphoid and Lunate. Clinics and Practice. 2011; 1(4):e87. https://doi.org/10.4081/cp.2011.e87

Chicago/Turabian Style

Koulali Idrissi, Khalid, and Farid Galiua. 2011. "Palmar Dislocation of Scaphoid and Lunate" Clinics and Practice 1, no. 4: e87. https://doi.org/10.4081/cp.2011.e87

Article Metrics

Back to TopTop